Melanoma, much better to prevent than to cure

10/07/2023.

Netherlands to provide free sun cream to tackle record skin cancer levels.

iToBoS project presented in a TV program in Catalonia

6/07/2023.

The iToBoS project was presented on the “Fet a mida” program, a daily television magazine broadcasting topics of general interest and current affairs of La Xarxa.

What French Melanoma patients know about AI use in their disease: a melanoma patient advocate observation in online forums

5/07/2023.

The MelanomeFrance forum is an online private forum of around 1500 Melanoma patients and carers, mostly from France, but also French speaking Belgians, Swiss, North Africans and Canadians.

Published 3 posters presenting iToBoS

2/07/0223.

Find here the three posters through wich the iToBoS project was presented in Vancouver, Canada.

iToBoS at 3rd International Symposium on Microgenomics 2023

1/07/2023. 

The 3rd International Symposium on Microgenomics 2023 was held in Florence (Italy) on 29-30 June.

Exosomal miRNA can be used to discriminate nevi from melanoma

30/06/2023.

Staging of melanoma and follow-up after melanoma diagnosis aim at predicting risk and detecting progression or recurrence at an early stage, respectively, in order to timely start and/or change treatment.

Containerization for iToBoS cloud services

27/06/2023.

Containerization is a method that allows to run multiple applications on a single host machine using isolated environments called containers.

iToBoS project presented on TV Girona

23/06/2023.

iToBoS project was presented on Televisió de Girona (TV Girona) on June 22, 2023.

iToBoS at CVPR'23 SAIAD workshop

22/06/2023.

iToBoS project was presented in the Safe Artificial Intelligence for All Domains (SAIAD) workshop, that took place at the CVPR2023 conference on computer vision, held in Vancouver, Canada, on June 18, 2023.

Optotune’s webinar on the iToBoS project

21/06/2023.

The iToBoS project has been featured in a webinar hosted by the simulation software company Ansys.